UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
AAR Corp
AIR
$5.89B
| $749K | ﹤0.01% |
23,498
+2,300
| +11% | +$70.2K |
|
1777
Granite Construction
GVA
$5.32B
| $749K | ﹤0.01% |
21,099
+2,200
| +12% | +$80.3K |
|
1778
Nelnet
NNI
$4.85B
| $749K | ﹤0.01% |
17,302
+2,000
| +13% | +$87.8K |
|
1779
AMN Healthcare
AMN
$1.19B
| $746K | ﹤0.01% |
23,615
+1,300
| +6% | +$34K |
|
1780
Comscore
SCOR
$113M
| $746K | ﹤0.01% |
700
+105
| +18% | +$113K |
|
|
AMAG
1781
DELISTED
AMAG Pharmaceuticals
AMAG
| $746K | ﹤0.01% |
10,799
+2,200
| +26% | +$138K |
|
|
DSCI
1782
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $746K | ﹤0.01% |
104,258
-50,093
| -32% | -$377K |
|
1783
TFS Financial
TFSL
$5.01B
| $743K | ﹤0.01% |
44,195
+2,500
| +6% | +$37.6K |
|
|
CSOD
1784
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $741K | ﹤0.01% |
21,300
-67,000
| -76% | -$2.08M |
|
|
WMC
1785
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $737K | ﹤0.01% |
4,990
+1,350
| +37% | +$202K |
|
1786
AB InBev
BUD
$165B
| $736K | ﹤0.01% |
6,100
-569
| -9% | -$69.8K |
|
|
SCS
1787
DELISTED
Steelcase
SCS
| $736K | ﹤0.01% |
38,897
+5,400
| +16% | +$98.8K |
|
1788
Super Micro Computer
SMCI
$19B
| $736K | ﹤0.01% |
248,980
+26,000
| +12% | +$85.6K |
|
1789
HealthEquity
HQY
$8.65B
| $734K | ﹤0.01% |
+22,900
| New | +$615K |
|
|
ALEX
1790
DELISTED
Alexander & Baldwin
ALEX
| $733K | ﹤0.01% |
18,599
+600
| +3% | +$24.7K |
|
1791
Dine Brands
DIN
$450M
| $733K | ﹤0.01% |
7,400
+1,000
| +16% | +$99.7K |
|
1792
Mine Safety
MSA
$7.48B
| $732K | ﹤0.01% |
15,099
+2,300
| +18% | +$110K |
|
1793
RingCentral
RNG
$5.18B
| $727K | ﹤0.01% |
39,300
+13,600
| +53% | +$237K |
|
|
KKD
1794
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $722K | ﹤0.01% |
37,498
+2,000
| +6% | +$37.1K |
|
|
OVTI
1795
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $720K | ﹤0.01% |
27,498
+3,500
| +15% | +$93.7K |
|
|
CATM
1796
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $719K | ﹤0.01% |
19,399
+2,600
| +15% | +$98.5K |
|
|
CYBX
1797
DELISTED
CYBERONICS INC
CYBX
| $719K | ﹤0.01% |
12,099
+1,300
| +12% | +$81.8K |
|
|
SYNT
1798
DELISTED
Syntel Inc
SYNT
| $717K | ﹤0.01% |
15,100
+3,100
| +26% | +$148K |
|
1799
International Bancshares
IBOC
$4.67B
| $715K | ﹤0.01% |
26,598
+3,400
| +15% | +$90.3K |
|
1800
Horace Mann Educators
HMN
$2.19B
| $713K | ﹤0.01% |
19,598
+2,700
| +16% | +$94.9K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.